share_log

60 Degrees Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities- Knight Therapeutics Inc

SEC announcement ·  Apr 4 06:04
Summary by Futu AI
Knight Therapeutics Inc, a former 10% owner of 60 Degrees Pharmaceuticals, has engaged in a planned transaction on July 28, 2023. The transaction involved the acquisition of 45,560 shares of common stock at a price of $4.745 per share and the disposal of 2,162 shares of Series A Non-Voting Convertible Preferred Stock at no cost. Following these transactions, Knight Therapeutics Inc's indirect beneficial ownership, through Knight Therapeutics International S.A., will amount to 78,803 shares of 60 Degrees Pharmaceuticals.
Knight Therapeutics Inc, a former 10% owner of 60 Degrees Pharmaceuticals, has engaged in a planned transaction on July 28, 2023. The transaction involved the acquisition of 45,560 shares of common stock at a price of $4.745 per share and the disposal of 2,162 shares of Series A Non-Voting Convertible Preferred Stock at no cost. Following these transactions, Knight Therapeutics Inc's indirect beneficial ownership, through Knight Therapeutics International S.A., will amount to 78,803 shares of 60 Degrees Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.